Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzaknen 5% Gel regimen for mild-to-moderate acne vulgaris
2015-001448-13Phase 4Completed
- Sponsor
- Galderma
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of benzoyl peroxide in acne vulgaris, sponsored by Galderma. Primary endpoint: Patient satisfaction. Started May 2015; status: completed.
02
Drugs
benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2015-001448-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001448-13.